Tang, Zhenye
Zhou, Chenfei
Xu, Yinyin
Chen, Zhizai
Huang, Shuting
Chen, Jing
Jin, Ping
Hu, Jiemei
He, Shanyang
Funding for this research was provided by:
National Natural Science Foundation of China (82103647, 82272850)
Guangzhou Municipal Science and Technology Project (202201010899)
National Health Commission Foundation of China (WKZX2023CX130001)
Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515010596)
The PARP Inhibitor Oncology Research Foundation (Phase IV) of Chinese Anti-Cancer Association (CETSDHRCORP252-4-026)
Article History
Received: 4 June 2025
Accepted: 6 September 2025
First Online: 17 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.